Healthcare billing and coding rely on precise nomenclature to ensure accurate reimbursement and clear communication between providers and payers. Among the most critical assessments are coagulation studies, where the prothrombin time (PT) and partial thromboplastin time (PTT) serve as frontline indicators of hemostatic function. To translate these diagnostic tests into a standardized billing language, specific Current Procedural Terminology (CPT) codes are utilized, forming the backbone of financial and clinical documentation in laboratories and outpatient settings.
Understanding the Core CPT Codes for Coagulation Studies
The American Medical Association (AMA) maintains the CPT code set, which provides a uniform language for reporting medical services. When it comes to coagulation testing, two primary standalone codes exist for the initial screening of the extrinsic and intrinsic pathways. These codes are designed for instances where only a single test is performed or when a provider specifically requests one without the other.
Code 85002: Prothrombin Time (PT)
Code 85002 is the designated CPT code for prothrombin time. This test measures the time it takes for blood to clot via the extrinsic pathway, which is dependent on factors produced by the liver, including factors VII, X, V, II, and fibrinogen. It is particularly sensitive to variations in Vitamin K levels and the effects of oral anticoagulants like warfarin. Medical billers must ensure that this code is not confused with the comprehensive metabolic panel or the basic metabolic panel, which contain entirely different procedural components.
Code 85014: Partial Thromboplastin Time (PTT)
Complementing the PT is code 85014, which identifies the partial thromboplastin time. This assay evaluates the intrinsic and common coagulation pathways, assessing factors XII, XI, IX, VIII, X, V, II, and fibrinogen. It is the primary screening tool for hemophilia and other intrinsic pathway disorders. Because this test often requires manual skill and precise temperature control, it is categorized under complex clinical laboratory testing protocols.
The Comprehensive Coagulation Panel: CPT 85010
In clinical practice, it is far more common for physicians to order both the PT and PTT simultaneously to gain a complete picture of a patient's coagulation status. To accommodate this, the AMA provides a specific combination code that streamlines the billing process. Using this single code indicates that the laboratory performed both the prothrombin and partial thromboplastin tests using identical methodology and sample aliquots.
Code 85010: Coagulation Studies
The CPT code 85010 is designated for "Coagulation studies; plasma fibrinogen determination; complete." However, in the context of standard medical billing, this code is widely recognized and reimbursed as the fee for performing both a PT and a PTT on the same patient encounter. This code represents a value-based approach to diagnostics, reducing the administrative burden of billing multiple line items for tests that are often drawn together in a single tube.
